Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance

Molly Javier Uyeda, Audrey Re, Chunyi Tang, Melissa McLaughlin, Daryl Humes, Steven Sexton, Robert Freeborn, Isaura Villalba, Kevin Nugent, James Adams, Jie Wei, Matt Breton, Xavier Paliard, Maximilian Richter, Maria Grazia Roncarolo, Ryan Bjordahl

Open source

DOI: 10.3389/fimmu.2026.1848770
Published: 2026-07-09
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1848770,
  title = {Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance},
  author = {Molly Javier Uyeda and Audrey Re and Chunyi Tang and Melissa McLaughlin and Daryl Humes and Steven Sexton and Robert Freeborn and Isaura Villalba and Kevin Nugent and James Adams and Jie Wei and Matt Breton and Xavier Paliard and Maximilian Richter and Maria Grazia Roncarolo and Ryan Bjordahl},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1848770},
  url = {https://doi.org/10.3389/fimmu.2026.1848770}
}

RIS

TY  - JOUR
TI  - Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance
AU  - Molly Javier Uyeda
AU  - Audrey Re
AU  - Chunyi Tang
AU  - Melissa McLaughlin
AU  - Daryl Humes
AU  - Steven Sexton
AU  - Robert Freeborn
AU  - Isaura Villalba
AU  - Kevin Nugent
AU  - James Adams
AU  - Jie Wei
AU  - Matt Breton
AU  - Xavier Paliard
AU  - Maximilian Richter
AU  - Maria Grazia Roncarolo
AU  - Ryan Bjordahl
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1848770
UR  - https://doi.org/10.3389/fimmu.2026.1848770
ER  -

APA

Uyeda, M. J., Re, A., Tang, C., McLaughlin, M., Humes, D., Sexton, S., Freeborn, R., Villalba, I., Nugent, K., Adams, J., Wei, J., Breton, M., Paliard, X., Richter, M., Roncarolo, M. G., & Bjordahl, R. (2026). Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1848770

Source records

crossref · retrieved 2026-09-27T01:11:26.537Z